
    
      This clinical study will use a multi-center, prospective design, to evaluate ProChondrix CR
      in approximately 80 patients who are scheduled to undergo treatment of a cartilage defect on
      the femoral condyle or patella.Patient follow-up will include a period of 60 months after
      surgery. During this follow-up period, each patient will be evaluated seven (7) times at: 3,
      6, 12, 24, 36, 48 and 60 months after surgical intervention.
    
  